Elektrotim Adopts Strategy For 2026-2030

About this update from Tryp Therapeutics, Inc.

Elektrotim SA GPW:ELT:ADOPTS STRATEGY FOR 2026-2030UNDER 2026-2030 STRATEGY COMPANY TO ALLOCATE BETWEEN 50% AND 75% OF ITS NET PROFIT FOR DIVIDEND DISTRIBUTIONUNDER 2026-2030 STRATEGY COMPANY TARGETS 1 BILLION PLN REVENUE IN 2030UNDER 2026-2030 STRATEGY COMPANY TARGETS EBITDA UP TO 88 MILLION ZLOTYS IN 2030UNDER 2026-2030 STRATEGY COMPANY TARGETS NET PROFIT AT 67 MILLION ZLOTYS IN 2030UNDER 2026-2030 STRATEGY COMPANY ALSO INCLUDES DIVIDEND POLICY

View stock analysis, news, and events for Tryp Therapeutics, Inc.